“…The rationale for the use of IGFGT in patients with short stature, in particular in those with apparent idiopathic short stature (ISS), is to determine whether reduced GH sensitivity is an explanation for the phenotype (10,12,13). Investigators have also used the IGFGT to assess whether GHI contributes to short stature associated with various medical conditions, such as b-thalassaemia (14,15,16,17), HIV infection in children (18), juvenile idiopathic arthritis (19), osteogenesis imperfecta (20), immunodeficiency (21) and Turner syndrome (22,23).…”